City of Hope and Mount Sinai Unlock New Treatment for Diabetes
Recent research published in Science Translational Medicine offers promising advancements in developing regenerative therapies for diabetes. A team of...
Pfizer: New Formulation of Oral GLP-1 Agonist Advances to Development Stage
Pfizer has selected a once-daily formulation of danuglipron, an oral GLP-1 receptor agonist, based on encouraging results from an...
Eye-Opening Advanced Therapy for Cancer Offers New Hope
We are excited to bring you an insightful conversation with Robert Towarnicki, Co-Founder and CEO of Sirpant Immunotherapeutics. In...
Pluristyx and Humacyte Announce Partnership
Pluristyx, a renowned cellular therapy developer, has partnered with Humacyte, a biotechnology company specializing in bioengineered human tissue. This...
Obsidian’s OBX-115 T-Cell Therapy For Melanoma Receives FDA Fast Track
Obsidian Therapeutics has secured Fast Track Designation from the FDA for OBX-115, an engineered T-cell therapy targeting metastatic or...
What You Need to Know About Clinical Trial Temperature Management Solutions
Maintaining drug stability and integrity is crucial in the rapidly advancing field of clinical trials and amidst global climate...
Remarkable Advances in EDC Systems You Need to Know
Zach Taft, CEO of health tech innovator Ignitedata, discusses the critical need for interoperability between Electronic Health Records (EHR)...
Antidote Strengthens Clinical Trial Enrollment Collaboration
SEQSTER and Antidote have revolutionized patient matching and clinical research efficiency. SEQSTER’s patient-centric healthcare platform provides a comprehensive view...
Genentech Unveils Second Chance for Susvimo to Combat AMD
The Food and Drug Administration (FDA) has approved updates to Susvimo, an eye implant treatment for wet age-related macular...
Human-Enabled AI Driving Enhancements in Clinical Trial Site Selection
Effective clinical trial site selection is crucial for the success of any clinical trial. It plays a pivotal role...